Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Maarten H L, Christiaans"'
Autor:
Emma T. M. Peereboom, Benedict M. Matern, Toshihide Tomosugi, Matthias Niemann, Julia Drylewicz, Irma Joosten, Wil A. Allebes, Arnold van der Meer, Luuk B. Hilbrands, Marije C. Baas, Franka E. van Reekum, Marianne C. Verhaar, Elena G. Kamburova, Marc A. J. Seelen, Jan Stephan Sanders, Bouke G. Hepkema, Annechien J. Lambeck, Laura B. Bungener, Caroline Roozendaal, Marcel G. J. Tilanus, Christien E. Voorter, Lotte Wieten, Elly M. van Duijnhoven, Mariëlle A. C. J. Gelens, Maarten H. L. Christiaans, Frans J. van Ittersum, Azam Nurmohamed, Neubury M. Lardy, Wendy Swelsen, Karlijn A. van der Pant, Neelke C. van der Weerd, Ineke J. M. ten Berge, Fréderike J. Bemelman, Aiko P. J. de Vries, Johan W. de Fijter, Michiel G. H. Betjes, Dave L. Roelen, Frans H. Claas, Henny G. Otten, Sebastiaan Heidt, Arjan D. van Zuilen, Takaaki Kobayashi, Kirsten Geneugelijk, Eric Spierings
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
CD4+ T-helper cells play an important role in alloimmune reactions following transplantation by stimulating humoral as well as cellular responses, which might lead to failure of the allograft. CD4+ memory T-helper cells from a previous immunizing eve
Externí odkaz:
https://doaj.org/article/304c2f59ef3743a597b164b0c8125533
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Prospective studies combining physical functioning (PF), physical activity (PA), and body composition (BC) after living donor transplantation/donation are scarce. We aimed to study differences in these parameters between kidney tr
Externí odkaz:
https://doaj.org/article/430e116ccb6d4b04a254425fa29ff17e
Autor:
Michèle J C de Kok, Alexander F M Schaapherder, Ian P J Alwayn, Frederike J Bemelman, Jacqueline van de Wetering, Arjan D van Zuilen, Maarten H L Christiaans, Marije C Baas, Azam S Nurmohamed, Stefan P Berger, Esther Bastiaannet, Rutger J Ploeg, Aiko P J de Vries, Jan H N Lindeman
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236662 (2020)
The use of kidneys donated after circulatory death (DCD) remains controversial due to concerns with regard to high incidences of early graft loss, delayed graft function (DGF), and impaired graft survival. As these concerns are mainly based on data f
Externí odkaz:
https://doaj.org/article/176129aa1f8943ea907e6ac08dcb4e64
Autor:
April C E van Gennip, Natascha J H Broers, Karlien J Ter Meulen, Bernard Canaud, Maarten H L Christiaans, Tom Cornelis, Mariëlle A C J Gelens, Marc M H Hermans, Constantijn J A M Konings, Jeroen B van der Net, Frank M van der Sande, Casper G Schalkwijk, Frank Stifft, Joris J J M Wirtz, Jeroen P Kooman, Remy J H Martens
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222547 (2019)
IntroductionEnd-stage renal disease (ESRD) strongly associates with cardiovascular disease (CVD) risk. This risk is not completely mitigated by renal replacement therapy. Endothelial dysfunction (ED) and low-grade inflammation (LGI) may contribute to
Externí odkaz:
https://doaj.org/article/783ee53c2bd44954a79d16e4b0e16d82
Autor:
Remy J H Martens, Natascha J H Broers, Bernard Canaud, Maarten H L Christiaans, Tom Cornelis, Adelheid Gauly, Marc M H Hermans, Constantijn J A M Konings, Frank M van der Sande, Jean L J M Scheijen, Frank Stifft, Joris J J M Wirtz, Jeroen P Kooman, Casper G Schalkwijk
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221058 (2019)
BackgroundCardiovascular disease (CVD) related mortality and morbidity are high in end-stage renal disease (ESRD). The pathophysiology of CVD in ESRD may involve non-traditional CVD risk factors, such as accumulation of advanced glycation endproducts
Externí odkaz:
https://doaj.org/article/bb69197ef0d941eea41070c4e3647c0e
Autor:
Elena G. Kamburova, Tineke Kardol-Hoefnagel, Bram W. Wisse, Irma Joosten, Wil A. Allebes, Arnold van der Meer, Luuk B. Hilbrands, Marije C. Baas, Eric Spierings, Cornelis E. Hack, Franka E. van Reekum, Arjan D. van Zuilen, Marianne C. Verhaar, Michiel L. Bots, Adriaan C. A. D. Drop, Loes Plaisier, Jan Meeldijk, Niels Bovenschen, Marc A. J. Seelen, Jan Stephan Sanders, Bouke G. Hepkema, Annechien J. A. Lambeck, Laura B. Bungener, Caroline Roozendaal, Marcel G. J. Tilanus, Christina E. Voorter, Lotte Wieten, Elly M. van Duijnhoven, Mariëlle A. C. J. Gelens, Maarten H. L. Christiaans, Frans J. van Ittersum, Shaikh A. Nurmohamed, Neubury M. Lardy, Wendy Swelsen, Karlijn A. M. I. van der Pant, Neelke C. van der Weerd, Ineke J. M. ten Berge, Frederike J. Bemelman, Paul J. M. van der Boog, Johan W. de Fijter, Michiel G. H. Betjes, Sebastiaan Heidt, Dave L. Roelen, Frans H. Claas, Henny G. Otten
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The best treatment for patients with end-stage renal disease is kidney transplantation. Although graft survival rates have improved in the last decades, patients still may lose their grafts partly due to the detrimental effects of donor-specific anti
Externí odkaz:
https://doaj.org/article/fdeb939922f44a558780ffa6a6f5a05f
Autor:
Kirsten Geneugelijk, Matthias Niemann, Julia Drylewicz, Arjan D. van Zuilen, Irma Joosten, Wil A. Allebes, Arnold van der Meer, Luuk B. Hilbrands, Marije C. Baas, C. Erik Hack, Franka E. van Reekum, Marianne C. Verhaar, Elena G. Kamburova, Michiel L. Bots, Marc A. J. Seelen, Jan Stephan Sanders, Bouke G. Hepkema, Annechien J. Lambeck, Laura B. Bungener, Caroline Roozendaal, Marcel G. J. Tilanus, Joris Vanderlocht, Christien E. Voorter, Lotte Wieten, Elly M. van Duijnhoven, Mariëlle Gelens, Maarten H. L. Christiaans, Frans J. van Ittersum, Azam Nurmohamed, Junior N. M. Lardy, Wendy Swelsen, Karlijn A. van der Pant, Neelke C. van der Weerd, Ineke J. M. ten Berge, Fréderike J. Bemelman, Andries Hoitsma, Paul J. M. van der Boog, Johan W. de Fijter, Michiel G. H. Betjes, Sebastiaan Heidt, Dave L. Roelen, Frans H. Claas, Henny G. Otten, Eric Spierings
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Individual HLA mismatches may differentially impact graft survival after kidney transplantation. Therefore, there is a need for a reliable tool to define permissible HLA mismatches in kidney transplantation. We previously demonstrated that donor-deri
Externí odkaz:
https://doaj.org/article/dfbc004143624e37972462011bc75b2a
Autor:
Thomas H P M Habets, Bouke G Hepkema, Niels Kouprie, Melanie C A Schnijderberg, Tim C van Smaalen, Laura B Bungener, Maarten H L Christiaans, Gerard M J Bos, Joris Vanderlocht
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203381 (2018)
Human leukocyte antigen (HLA)-DRB3 is a functional HLA class II gene, which has a limited allele diversity in the human population. Furthermore, the HLA-DRB3 gene is only present in a subset of individuals. Therefore, in organ transplantation, this H
Externí odkaz:
https://doaj.org/article/f012e0b9853e47edb31fbf6397a7d96d
Autor:
Sohal Y Ismail, L W Ernest van Heurn, Jacqueline van de Wetering, Jan N M IJzermans, Kirsten Kortram, Emerentia Q W Spoon, Frank C H d'Ancona, Maarten H L Christiaans, H Sijbrand Hofker, Arjan W J Hoksbergen, Jaap J Homan van der Heide, Mirza M Idu, Caspar W N Looman, S Azam Nurmohamed, Jan Ringers, Raechel J Toorop, Frank J M F Dor
Publikováno v:
BMJ Open, Vol 6, Iss 4 (2016)
Introduction Informed consent is mandatory for all (surgical) procedures, but it is even more important when it comes to living kidney donors undergoing surgery for the benefit of others. Donor education, leading to informed consent, needs to be carr
Externí odkaz:
https://doaj.org/article/466548295bde4b1185dce6765e5043a8
Autor:
Jan H.N. Lindeman, Alexander F. Schaapherder, Maarten H. L. Christiaans, Michèle J. de Kok, Cynthia Konijn, Arjan D. van Zuilen, Jacqueline van de Wetering, Rutger J. Ploeg, Marije C. Baas, Jacobus W. Mensink, Azam S. Nurmohamed, Ian P.J. Alwayn, Frederike J. Bemelman, Stefan P Berger, Marlies E.J. Reinders, Aiko P. J. de Vries
Publikováno v:
Kidney International, 97(6), 1243-1252. ELSEVIER SCIENCE INC
de Kok, M J, Schaapherder, A F, Mensink, J W, de Vries, A P, Reinders, M E, Konijn, C, Bemelman, F J, van de Wetering, J, van Zuilen, A D, Christiaans, M H, Baas, M C, Nurmohamed, A S, Berger, S P, Ploeg, R J, Alwayn, I P & Lindeman, J H 2020, ' A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss ', Kidney International, vol. 97, no. 6, pp. 1243-1252 . https://doi.org/10.1016/j.kint.2020.01.043
Kidney International, 97(6), 1243-1252. Nature Publishing Group
Kidney international, 97(6), 1243-1252. Nature Publishing Group
Kidney International, 97, 6, pp. 1243-1252
Kidney International, 97(6), 1243-1252. Elsevier Science
Kidney International, 97(6), 1243-1252. Elsevier Inc.
Kidney International, 97, 1243-1252
de Kok, M J, Schaapherder, A F, Mensink, J W, de Vries, A P, Reinders, M E, Konijn, C, Bemelman, F J, van de Wetering, J, van Zuilen, A D, Christiaans, M H, Baas, M C, Nurmohamed, A S, Berger, S P, Ploeg, R J, Alwayn, I P & Lindeman, J H 2020, ' A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss ', Kidney International, vol. 97, no. 6, pp. 1243-1252 . https://doi.org/10.1016/j.kint.2020.01.043
Kidney International, 97(6), 1243-1252. Nature Publishing Group
Kidney international, 97(6), 1243-1252. Nature Publishing Group
Kidney International, 97, 6, pp. 1243-1252
Kidney International, 97(6), 1243-1252. Elsevier Science
Kidney International, 97(6), 1243-1252. Elsevier Inc.
Kidney International, 97, 1243-1252
Early graft loss (EGL) is a feared outcome of kidney transplantation. Consequently, kidneys with an anticipated risk of EGL are declined for transplantation. In the most favorable scenario, with optimal use of available donor kidneys, the donor pool